RNA Therapeutics: Informational drugs as a pandemic response tool
Authors
Khvorova, AnastasiaDocument Type
PresentationPublication Date
2020-04-30Keywords
2019-nCoVCOVID-19
SARS-2-CoV
SARS-2
2019 novel coronavirus disease
pandemic
clinical and translational science
CTSA
Massachusetts
research
Biochemistry, Biophysics, and Structural Biology
Infectious Disease
Medicinal Chemistry and Pharmaceutics
Medicinal-Pharmaceutical Chemistry
Translational Medical Research
Virus Diseases
Metadata
Show full item recordAbstract
This presentation, hosted by the Community Engagement and Research Section, University of Massachusetts Medical School Center for Clinical and Translational Science, describes the development of siRNA-based approaches for modulation of COVID-19 in the lung in a three-month time frame. This talk was the second in the COVID-19 Research Community Forum webinar series, a collaboration of the four federally-funded Clinical and Translational Science Awardees (CTSA) in Massachusetts, that provided an opportunity for community members, institutions and other organizations to be part of the discussions surrounding the COVID-19 pandemic. The MA CTSAs, consisting of the UMass Center for Clinical and Translational Science, Tufts Clinical and Translational Science Institute, Harvard Catalyst, and Boston University Clinical and Translational Science Institute, offered community forums with researchers to hear about COVID-19 research happening here in Massachusetts.DOI
10.13028/v3re-kf81Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50557Related Resources
https://vimeo.com/413926641/de73d501b4Rights
Copyright 2020 The Author(s)ae974a485f413a2113503eed53cd6c53
10.13028/v3re-kf81